Matica Biotechnology | Greater Brazos Partnership

Matica Biotechnology (Matica Bio) is a cell and gene therapy CDMO that brings together integrated GMP manufacturing platforms and innovative solutions resulting in speed to clinic without sacrificing quality. Their investments in advanced, single-use equipment, the latest analytical techniques, and industry-leading expertise support their mission — delivering on their commitment to their clients' success from idea to patient.

Their Story

Matica Bio was founded in 2019 in College Station, Texas. Immediately after its foundation, the company announced the groundbreaking for its 25,000 sqft. GMP facility, which was completed roughly a year after the initiation. At its state-of-art GMP manufacturing site, Matica Bio offers industry-leading cell and viral vector manufacturing services to its clients worldwide.

How They Help

As an expert CDMO in cell and gene therapies, Matica Bio delivers innovative manufacturing solutions through operational excellence, accelerating delivery of high quality therapies to patients’ bedside.

"At Matica Bio, we are passionate about delivering on the promise of our clients’ therapies, helping patients improve their quality of life. As a trusted manufacturing partner, Matica Bio aspires to build on our expertise, technologies, and processes to realize the potential of these innovative medicines."

Yun Jeong Song

CEO, Matica Biotechnology

Where They Are Going

Matica Bio’s vision is to become a leading global CDMO in manufacturing advanced therapies to help improve patients’ lives. From its base in the rapidly growing Texas biomedical corridor, Matica Bio aims to further expand its business in Brazos Valley, increasing both its capacity and capabilities.

Visit Their Website

Matica Biotechnology